Inflammation and the pathogenesis of age-related macular degeneration
暂无分享,去创建一个
[1] Hermann b. Pagenstecher,et al. Atlas der pathologischen Anatomie des Augapfels , 2011 .
[2] E. Souied,et al. [Epidemiology of age related macular degeneration]. , 2009, Journal francais d'ophtalmologie.
[3] B. Klein,et al. Combined effects of complement factor H genotypes, fish consumption, and inflammatory markers on long-term risk for age-related macular degeneration in a cohort. , 2008, American journal of epidemiology.
[4] R. Klein,et al. Inflammation, complement factor h, and age-related macular degeneration: the Multi-ethnic Study of Atherosclerosis. , 2008, Ophthalmology.
[5] K. Tsubota,et al. Inhibition of choroidal neovascularization with an anti-inflammatory carotenoid astaxanthin. , 2008, Investigative ophthalmology & visual science.
[6] P. Mitchell,et al. The LOC387715 polymorphism, inflammatory markers, smoking, and age-related macular degeneration. A population-based case-control study. , 2008, Ophthalmology.
[7] Joe G Hollyfield,et al. Oxidative damage–induced inflammation initiates age-related macular degeneration , 2008, Nature Medicine.
[8] P. Debré,et al. CX3CR1-dependent subretinal microglia cell accumulation is associated with cardinal features of age-related macular degeneration. , 2007, The Journal of clinical investigation.
[9] A. Hofman,et al. C-reactive protein level and risk of aging macula disorder: The Rotterdam Study. , 2007, Archives of ophthalmology.
[10] Lois E. H. Smith,et al. Overstaying their welcome: defective CX3CR1 microglia eyed in macular degeneration. , 2007, The Journal of clinical investigation.
[11] H. Hense,et al. Modeling smoking history: a comparison of different approaches in the MARS study on age-related maculopathy. , 2007, Annals of epidemiology.
[12] E. B. Rodrigues,et al. Inflammation in Dry Age-Related Macular Degeneration , 2007, Ophthalmologica.
[13] R. Apte,et al. Macrophages Inhibit Neovascularization in a Murine Model of Age-Related Macular Degeneration , 2006, PLoS medicine.
[14] Usha Chakravarthy,et al. Prevalence of age-related maculopathy in older Europeans: the European Eye Study (EUREYE). , 2006, Archives of ophthalmology.
[15] Alston Callahan,et al. The role of inflammation in the pathogenesis of age-related macular degeneration. , 2006, Survey of ophthalmology.
[16] P. Mcgeer,et al. Inflammation, the complement system and the diseases of aging , 2005, Neurobiology of Aging.
[17] M. Tso,et al. Activation of microglia and chemokines in light-induced retinal degeneration. , 2005, Molecular vision.
[18] P. Mitchell,et al. Smoking and age-related macular degeneration: a review of association , 2005, Eye.
[19] R. T. Smith,et al. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[20] Ning Zhang,et al. Neutrophils promote experimental choroidal neovascularization. , 2005, Molecular vision.
[21] J. Gilbert,et al. Complement Factor H Variant Increases the Risk of Age-Related Macular Degeneration , 2005, Science.
[22] A. Edwards,et al. Complement Factor H Polymorphism and Age-Related Macular Degeneration , 2005, Science.
[23] J. Ott,et al. Complement Factor H Polymorphism in Age-Related Macular Degeneration , 2005, Science.
[24] S. Daiger,et al. Was the Human Genome Project Worth the Effort? , 2005, Science.
[25] B. Munoz,et al. Racial variations in causes of vision loss in nursing homes: The Salisbury Eye Evaluation in Nursing Home Groups (SEEING) Study. , 2004, Archives of ophthalmology.
[26] R. Klein,et al. Causes and prevalence of visual impairment among adults in the United States. , 2004, Archives of ophthalmology.
[27] Benita J. O’Colmain,et al. Prevalence of age-related macular degeneration in the United States. , 2004, Archives of ophthalmology.
[28] T. Peto,et al. The epidemiology of age-related macular degeneration. , 2004, American journal of ophthalmology.
[29] Eiji Sakurai,et al. An animal model of age-related macular degeneration in senescent Ccl-2- or Ccr-2-deficient mice , 2003, Nature Medicine.
[30] J. Ambati,et al. Macrophage depletion inhibits experimental choroidal neovascularization. , 2003, Investigative ophthalmology & visual science.
[31] K. Csaky,et al. Macrophage depletion diminishes lesion size and severity in experimental choroidal neovascularization. , 2003, Investigative ophthalmology & visual science.
[32] Robert F. Mullins,et al. An Integrated Hypothesis That Considers Drusen as Biomarkers of Immune-Mediated Processes at the RPE-Bruch's Membrane Interface in Aging and Age-Related Macular Degeneration , 2001, Progress in Retinal and Eye Research.
[33] J. Neitz,et al. Local cellular sources of apolipoprotein E in the human retina and retinal pigmented epithelium: implications for the process of drusen formation. , 2001, American journal of ophthalmology.
[34] M. Gillies,et al. Immunological and Aetiological Aspects of Macular Degeneration , 2001, Progress in Retinal and Eye Research.
[35] R. Klein,et al. Sunlight and the 5-year incidence of early age-related maculopathy: the beaver dam eye study. , 2001, Archives of ophthalmology.
[36] N. Bressler. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2. , 2001 .
[37] M. Boulton,et al. The role of oxidative stress in the pathogenesis of age-related macular degeneration. , 2000, Survey of ophthalmology.
[38] L. V. Johnson,et al. A potential role for immune complex pathogenesis in drusen formation. , 2000, Experimental eye research.
[39] J D Gottsch,et al. Oxidative damage and age-related macular degeneration. , 1999, Molecular vision.
[40] H. Hammes,et al. Nε(carboxymethyl)lysin and the AGE receptor RAGE colocalize in age-related macular degeneration , 1999 .
[41] R. Guymer,et al. Changes in Bruch’s membrane and related structures with age , 1999, Progress in Retinal and Eye Research.
[42] S. Horiuchi,et al. Advanced glycation end products in age-related macular degeneration. , 1998, Archives of ophthalmology.
[43] E. Rodriguez-Boulan,et al. Morphogenesis of the Retinal Pigment Epithelium: Toward Understanding Retinal Degenerative Diseases a , 1998, Annals of the New York Academy of Sciences.
[44] A. Kijlstra,et al. Polarized secretion of IL‐6 and IL‐8 by human retinal pigment epithelial cells , 1998, Clinical and experimental immunology.
[45] S. Line,et al. Trace Element Status and Free Radical Defense in Elderly Rhesus Macaques (Macaca mulatta) with Macular Drusen , 1995, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[46] P T de Jong,et al. Morphometric analysis of Bruch's membrane, the choriocapillaris, and the choroid in aging. , 1994, Investigative ophthalmology & visual science.
[47] A. Bird,et al. Correlation between biochemical composition and fluorescein binding of deposits in Bruch's membrane. , 1992, Ophthalmology.
[48] V. Sorrenti,et al. Lipid peroxidation and antioxidant enzymatic systems in rat retina as a function of age , 1992, Neurochemical Research.
[49] A. Bird,et al. Aging changes in Bruch's membrane. A histochemical and morphologic study. , 1990, Ophthalmology.
[50] L. E. Rikans,et al. Effect of aging on aqueous-phase antioxidants in tissues of male Fischer rats. , 1988, Biochimica et biophysica acta.
[51] Robert B Sim,et al. Assignment of complement components C4 binding protein (C4BP) and factor H (FH) to human chromosome 1q, using cDNA probes , 1988, Annals of human genetics.
[52] Robert B Sim,et al. The complete amino acid sequence of human complement factor H. , 1988, The Biochemical journal.
[53] M. Vandewoude,et al. Vitamin E status in a normal population: the influence of age. , 1987, Journal of the American College of Nutrition.
[54] L. Feeney-Burns,et al. Aging human RPE: morphometric analysis of macular, equatorial, and peripheral cells. , 1984, Investigative ophthalmology & visual science.
[55] C. Clemente. HISTOLOGY OF THE HUMAN EYE : An Atlas and Textbook , 1973 .
[56] K. Sandvig. CENTRAL, AREOLAR CHOROIDAL ATROPHY , 1959, Acta ophthalmologica.
[57] Neil M Bressler,et al. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization-verteporfin in photodynamic therapy report 2. , 2002, American journal of ophthalmology.
[58] V. Perry,et al. Dendritic cells in inflammatory responses in the CNS. , 1997, Advances in experimental medicine and biology.
[59] F S Rosenthal,et al. The long-term effects of visible light on the eye. , 1992, Archives of ophthalmology.
[60] A. Augustin,et al. Intestinal, hepatic and renal production of thiobarbituric acid reactive substances and myeloperoxidase activity after temporary aortic occlusion and reperfusion. , 1991, Life sciences.
[61] R. W. Young. Solar radiation and age-related macular degeneration. , 1988, Survey of ophthalmology.
[62] A. Bird,et al. Retinal pigment epithelial detachments in the elderly. , 1986, Transactions of the ophthalmological societies of the United Kingdom.